Peptirna Therapeutics Overview

  • Status
  • Private

  • Latest Deal Type
  • Seed

  • Investors
  • 1

Peptirna Therapeutics General Information

Description

Developer of peptide-based siRNA drug delivery technologies designed to enable targeted RNA interference therapies beyond liver cells. The company has developed a delivery vehicle that combines custom peptides with siRNA drugs to transport them into target cells outside the liver and incorporates technology to help siRNA escape endosomal degradation after cellular uptake, enabling biotechnology and pharmaceutical developers to broaden and optimize siRNA therapeutics.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Seongnam
  • South Korea
Primary Industry
Drug Delivery
Vertical(s)
Life Sciences
Corporate Office
  • Seongnam
  • South Korea

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Peptirna Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Seed Round 24-Dec-2025 Completed Startup
1. Accelerator/Incubator 01-Jan-2025 Completed Startup
To view Peptirna Therapeutics’s complete valuation and funding history, request access »

Peptirna Therapeutics Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds
WOW Partners Venture Capital Minority
To view Peptirna Therapeutics’s complete investors history, request access »

Ready to get started?

Request a free trial

Peptirna Therapeutics FAQs

  • Where is Peptirna Therapeutics headquartered?

    Peptirna Therapeutics is headquartered in Seongnam, South Korea.

  • What industry is Peptirna Therapeutics in?

    Peptirna Therapeutics’s primary industry is Drug Delivery.

  • Is Peptirna Therapeutics a private or public company?

    Peptirna Therapeutics is a Private company.

  • What is Peptirna Therapeutics’s current revenue?

    The current revenue for Peptirna Therapeutics is .

  • Who are Peptirna Therapeutics’s investors?

    WOW Partners has invested in Peptirna Therapeutics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process